|
業務類別
|
Biotechnology |
|
業務概覽
|
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease. |
| 公司地址
| 2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103 |
| 電話號碼
| +1 336 999-7019 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.prokidney.com |
| 員工數量
| 231 |
| Mr. James Coulston, C.P.A. |
Chief Financial Officer and Principal Accounting Officer |
美元 465.92K |
17/04/2026 |
| Dr. Bruce Culleton, M.D. |
Chief Executive Officer and Director |
美元 687.74K |
17/04/2026 |
| Dr. Darin J. Weber, PhD |
Chief Regulatory Officer |
-- |
17/04/2026 |
| Mr. Todd C. Girolamo, J.D.,M.B.A. |
Chief Legal Officer |
美元 466.15K |
17/04/2026 |
|
|
| Mr. Jose Ignacio Jimenez Santos |
Independent Director |
17/04/2026 |
| Ms. Jennifer A. Fox |
Independent Director |
17/04/2026 |
| Mr. Pablo Legorreta |
Chairman of the Board |
17/04/2026 |
| Dr. Bruce Culleton, M.D. |
Chief Executive Officer and Director |
17/04/2026 |
| Dr. Uma Sinha, PhD |
Independent Director |
17/04/2026 |
| Dr. Alan M. Lotvin, M.D. |
Independent Director |
17/04/2026 |
| Mr. William F. Doyle |
Lead Independent Director |
17/04/2026 |
| Dr. Brian J.G. Pereira,M.D. |
Independent Director |
17/04/2026 |
|
|
|
|
